-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) is a widely used intermediate in the production of various downstream chemical products.
In the chemical industry, the term "upstream" and "downstream" are used to refer to different stages of the production process.
In simple terms, upstream refers to the stage where raw materials are sourced and processed, while downstream refers to the stage where these raw materials are transformed into finished products.
L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) is an upstream product, as it is used as a raw material in the production of downstream chemical products.
It is an important intermediate in the production of several pharmaceuticals, including antiviral drugs and antibiotics.
The manufacturing process for L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) involves several steps, including the synthesis of the starting material and its subsequent purification.
The starting material is typically synthesized through a series of chemical reactions, using raw materials such as amino acids and organic compounds.
The resulting product is then purified through a series of chromatography and crystallization steps to remove any impurities.
Once the upstream product, L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) is produced, it can be used as a critical raw material in the production of several downstream chemical products.
One of the most common downstream products produced using L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) is the antiviral drug Tenofovir Disoproxil Fumarate.
Tenofovir Disoproxil Fumarate is used to treat HIV and hepatitis B virus infections.
It is produced by a series of chemical reactions that involve the use of L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) as an important intermediate.
Another downstream product that can be produced using L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) is the antibiotic Ceftriaxone.
Ceftriaxone is a third-generation cephalosporin antibiotic that is used to treat a wide range of bacterial infections.
It is produced through a series of chemical reactions that involve the use of L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) as a critical intermediate.
In addition to Tenofovir Disoproxil Fumarate and Ceftriaxone, L-